Literature DB >> 11434476

Ultrasonography and colour doppler sonography of salivary glands in primary Sjögren's syndrome.

M Carotti1, F Salaffi, P Manganelli, G Argalia.   

Abstract

To examine either the ultrasonographic (US) features of the parotids and submandibular glands or the blood flow alterations that may occur in the salivary glands of patients with primary Sjögren's syndrome (pSS) we studied 30 female patients with pSS and 30 controls suffering from dry mouth not due to pSS. All measurements were taken by the same examiner, who used the same equipment to avoid interobserver variability. The US parameters recorded (parenchymal homogeneity, echogenicity, size of the glands and posterior glandular border) were scored according to a previously described scoring system. For each waveform, peak systolic velocity (PSV) and resistive index (RI) were measured at the external carotid artery in the examination of the parotids and at the facial artery within the submandibular glands before and during lemon juice stimulation. On the basis of the degree of chronic inflammatory changes at minor salivary gland (MSG) biopsy, chronic sialadenitis (CS) was defined as mild in 10 and severe in 20 pSS patients. Abnormal US scores were obtained in 26/30 (86.6%) pSS patients and in 9/30 (30%) controls. Moreover, in pSS patients the US scores were sigificantly higher than in the control group (p=-0.0001). The mean (+/- SD) difference between the PSV values taken from parotids and submandibular glands before and during lemon juice stimulation was statistically significant (p=0.003 and p=0.01, respectively) in the controls. On the other hand, no significant changes in the PSV values were found in the whole group of pSS patients. However, the changes in PSV values before and during lemon juice stimulation were statistically significant in both parotids (p=0.019) and submandibular glands (p=0.012), and not significantly different from those in the controls in pSS patients with mild CS. The variability of RI taken from the salivary glands before and during lemon juice stimulation was not statistically significant in either pSS patients or controls. US abnormalities were detected in the majority of pSS patients and their severity was significantly greater than those recorded in the controls. Of the colour Doppler sonographic (CDS) parameters only PSV was influenced by the degree of chronic inflammation, as shown at the MSG biopsy, suggesting that PSV may reflect the vascular changes occurring in the salivary glands during the course of an autoimmune disease such as pSS.

Entities:  

Mesh:

Year:  2001        PMID: 11434476     DOI: 10.1007/s100670170068

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

1.  Elevated body mass index correlates with higher seminal plasma interleukin 8 levels and ultrasonographic abnormalities of the prostate in men attending an andrology clinic for infertility.

Authors:  F Lotti; G Corona; G M Colpi; E Filimberti; S Degli Innocenti; M Mancini; E Baldi; I Noci; G Forti; L Adorini; M Maggi
Journal:  J Endocrinol Invest       Date:  2011-07-07       Impact factor: 4.256

2.  Ultrasound analysis of mental artery flow in elderly patients: a case-control study.

Authors:  Marina G Baladi; Raul R C M Tucunduva Neto; Arthur R G Cortes; Eduardo M Aoki; Emiko S Arita; Claudio F Freitas
Journal:  Dentomaxillofac Radiol       Date:  2015-07-24       Impact factor: 2.419

3.  Multiple microlithiasis in bilateral parotid glands as the initial clinical manifestation of primary Sjögren's syndrome.

Authors:  Adrienn Dobai; Levente Pataky; József Barabás
Journal:  Oral Radiol       Date:  2017-06-12       Impact factor: 1.852

4.  Salivary gland ultrasonography: a highly specific tool for the early diagnosis of primary Sjögren's syndrome.

Authors:  Chiara Baldini; Nicoletta Luciano; Gaia Tarantini; Rachele Pascale; Francesca Sernissi; Marta Mosca; Davide Caramella; Stefano Bombardieri
Journal:  Arthritis Res Ther       Date:  2015-05-28       Impact factor: 5.156

5.  Salivary gland ultrasound abnormalities in primary Sjögren's syndrome: consensual US-SG core items definition and reliability.

Authors:  Sandrine Jousse-Joulin; Emmanuel Nowak; Divi Cornec; Jackie Brown; Andrew Carr; Marina Carotti; Benjamin Fisher; Joel Fradin; Alojzija Hocevar; Malin V Jonsson; Nicoletta Luciano; Vera Milic; John Rout; Elke Theander; Aaltje Stel; Hendrika Bootsma; Arjan Vissink; Chiara Baldini; Alan Baer; Wan Fai Ng; Simon Bowman; Zarrin Alavi; Alain Saraux; Valérie Devauchelle-Pensec
Journal:  RMD Open       Date:  2017-06-09

6.  Ultrasound assessment of salivary glands in patients with primary Sjögren's syndrome treated with rituximab: Quantitative and Doppler waveform analysis.

Authors:  Sandrine Jousse-Joulin; Valérie Devauchelle-Pensec; Johanne Morvan; Bruno Guias; Yvon Pennec; Jacques-Olivier Pers; Capucine Daridon; Christophe Jamin; Yves Renaudineau; Isabelle Quintin Roué; Béatrice Cochener; Luc Bressollette; Pierre Youinou; Alain Saraux
Journal:  Biologics       Date:  2007-09

7.  Metabolic syndrome and prostate abnormalities in male subjects of infertile couples.

Authors:  Francesco Lotti; Giovanni Corona; Linda Vignozzi; Matteo Rossi; Elisa Maseroli; Sarah Cipriani; Mauro Gacci; Gianni Forti; Mario Maggi
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

Review 8.  The usefulness of ultrasound in the diagnostics of Sjögren's syndrome.

Authors:  Fadhil Saied; Monika Włodkowska-Korytkowska; Maria Maślińska; Brygida Kwiatkowska; Wojciech Kunisz; Patrycja Smorawińska; Iwona Sudoł-Szopińska
Journal:  J Ultrason       Date:  2013-06-30

Review 9.  Standards for the assessment of salivary glands - an update.

Authors:  Piotr Zajkowski; Aleksandra Ochal-Choińska
Journal:  J Ultrason       Date:  2016-06-29

10.  Vascular mapping of the face: B-mode and doppler ultrasonography study.

Authors:  M-J Tucunduva; R Tucunduva-Neto; M Saieg; A-L Costa; C de Freitas
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.